company background image
4195 logo

Genomics BioSci & Tech.Ltd TPEX:4195 Stock Report

Last Price

NT$19.05

Market Cap

NT$1.4b

7D

5.5%

1Y

-3.3%

Updated

25 Apr, 2024

Data

Company Financials

Genomics BioSci & Tech. Co.,Ltd.

TPEX:4195 Stock Report

Market Cap: NT$1.4b

4195 Stock Overview

Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company.

4195 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 4195 from our risk checks.

Genomics BioSci & Tech. Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Genomics BioSci & Tech.Ltd
Historical stock prices
Current Share PriceNT$19.05
52 Week HighNT$26.08
52 Week LowNT$17.60
Beta0.26
1 Month Change-0.26%
3 Month Change-8.41%
1 Year Change-3.33%
3 Year Change21.59%
5 Year Change23.10%
Change since IPO-37.85%

Recent News & Updates

Recent updates

Is Genomics BioSci & Tech. Co.,Ltd.'s (GTSM:4195) 7.2% Dividend Worth Your Time?

Apr 27
Is Genomics BioSci & Tech. Co.,Ltd.'s (GTSM:4195) 7.2% Dividend Worth Your Time?

Key Things To Consider Before Buying Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) For Its Dividend

Jan 19
Key Things To Consider Before Buying Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) For Its Dividend

Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Nov 25
Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Shareholder Returns

4195TW BiotechsTW Market
7D5.5%-1.1%-0.6%
1Y-3.3%-21.5%29.2%

Price Volatility

Is 4195's price volatile compared to industry and market?
4195 volatility
4195 Average Weekly Movement2.1%
Biotechs Industry Average Movement4.8%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.7%
10% least volatile stocks in TW Market2.2%

About the Company

FoundedEmployeesCEOWebsite
2001n/aKevin Chiangwww.genomics.com.tw

Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company. It offers regular DNA, complex sequence, and TAF certificated sequencing services, as well as free sequencing primer and primer walking services; peptide, gene, and oligo synthesis services; and sample preparation, gene expression analysis, genotyping analysis, DNA methylation analysis, and microbial identification services.

Genomics BioSci & Tech. Co.,Ltd. Fundamentals Summary

How do Genomics BioSci & Tech.Ltd's earnings and revenue compare to its market cap?
4195 fundamental statistics
Market capNT$1.38b
Earnings (TTM)-NT$168.07m
Revenue (TTM)NT$396.14m

3.5x

P/S Ratio

-8.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4195 income statement (TTM)
RevenueNT$396.14m
Cost of RevenueNT$276.23m
Gross ProfitNT$119.91m
Other ExpensesNT$287.98m
Earnings-NT$168.07m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-2.32
Gross Margin30.27%
Net Profit Margin-42.43%
Debt/Equity Ratio35.1%

How did 4195 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.